rs1554428170
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000238.4(KCNH2):c.470delC(p.Pro157GlnfsTer9) variant causes a frameshift, splice region change. The variant was absent in control chromosomes in GnomAD project. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000238.4 frameshift, splice_region
Scores
Clinical Significance
Conservation
Publications
- long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- long QT syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- short QT syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- short QT syndrome type 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Brugada syndromeInheritance: AD Classification: MODERATE, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000238.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KCNH2 | NM_000238.4 | MANE Select | c.470delC | p.Pro157GlnfsTer9 | frameshift splice_region | Exon 3 of 15 | NP_000229.1 | ||
| KCNH2 | NM_001406753.1 | c.182delC | p.Pro61GlnfsTer9 | frameshift splice_region | Exon 1 of 13 | NP_001393682.1 | |||
| KCNH2 | NM_172056.3 | c.470delC | p.Pro157GlnfsTer9 | frameshift splice_region | Exon 3 of 9 | NP_742053.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KCNH2 | ENST00000262186.10 | TSL:1 MANE Select | c.470delC | p.Pro157GlnfsTer9 | frameshift splice_region | Exon 3 of 15 | ENSP00000262186.5 | ||
| KCNH2 | ENST00000713710.1 | c.470delC | p.Pro157GlnfsTer9 | frameshift splice_region | Exon 3 of 15 | ENSP00000519013.1 | |||
| KCNH2 | ENST00000713701.1 | c.170delC | p.Pro57GlnfsTer9 | frameshift splice_region | Exon 2 of 14 | ENSP00000519004.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Long QT syndrome Pathogenic:1
This variant has not been reported in the literature in individuals with KCNH2-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Pro157Glnfs*9) in the KCNH2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KCNH2 are known to be pathogenic (PMID: 19862833). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at